Eurobio Scientific offers a new proprietary test for simultaneous detection of the SARS-CoV-2 virus and characterization of its new mutations of interest
Eurobio Scientific offers a new proprietary test for simultaneous detection of the SARS-CoV-2 virus and characterization of its new mutations of interest Paris, May 26, 2021 – 7:30 am Eurobio Scientific (FR0013240934, ALERS, PEA-PME eligible), a leading French group in the field of specialty in vitro medical diagnostics, announces today the availability of its new proprietary EurobioPlex SARS-CoV-2 SNPs test (EBX-046), a real-time multiplex PCR* test for the detection of the SARS-CoV-2 coronavirus and the simultaneous typing of its new mutations. EBX-046 is a diagnostics test developed ...
Source: yahoo.com